Quality of life with deferasirox for iron overload
Part of Blood & lymphatic, Genetic & congenital, Hormones & metabolism clinical trials.
This study aims to see how well the iron-removing medicine deferasirox works in people with chronic iron overload from conditions like beta-thalassemia, and how it affects their quality of life. Participants will continue taking deferasirox as part of their normal care, and the study will track their health and well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years of age or older.
- You have beta-thalassemia (a blood disorder) or another type of anemia that causes iron buildup from blood transfusions or natural causes.
- You are currently taking deferasirox (a medicine that removes extra iron) and are willing to continue taking it at a dose of at least 900 mg.
- You do not have a blood disorder called myelodysplastic syndrome.
- You are not taking other iron-removing medicines like deferoxamine or deferiprone during the study.
- You can provide medical records from the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial studies HGI-002 to see if it’s safe and can help people with severe alpha thalassemia who need frequent blood transfusions. It also requires planning for a special treatment approach that includes busulfan pre-treatment and stem cell transplantation.
This trial tests whether a higher or lower dose of iron works better for people on peritoneal dialysis who have low iron levels. It aims to find the best way to treat iron deficiency in this group.
This Phase 2 study tests SP-420 to help people with transfusion-related iron overload from either beta-thalassemia or low-risk myelodysplastic syndromes. It aims to see if the treatment can improve how the body handles excess iron, which builds up after repeated transfusions.
This trial tests if adding a special starch and a drug called deferasirox can improve recovery for people who have a stem cell transplant for blood disorders. The starch may help with gut health and the drug reduces iron, which might help prevent complications.
This study tests an iron injection for treating iron deficiency anemia. It checks how the medicine works in the body, and may help people whose blood iron is too low.
This trial tests whether giving iron through an IV can help older adults with heart failure who also have low iron levels. It aims to see if this treatment improves symptoms and quality of life.
Hear when a new Thalassemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.